| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |